Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study

Anaesthesia

Volumn 70, Issue 11, 2015, Pages 1264-1267

  Platt, P R ^a   Clarke, R C ^a   Johnson, G H ^a   Sadleir, P H M ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; ANTIINFECTIVE AGENT; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ANAPHYLAXIS; ANESTHESIA INDUCTION; ARTICLE; AUSTRALIA; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; HUMAN; OUTCOME ASSESSMENT; RESUSCITATION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; CHEMICALLY INDUCED; DRUG EFFECTS; HEMODYNAMICS; TREATMENT OUTCOME;

ANAPHYLAXIS; ANDROSTANOLS; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; GAMMA-CYCLODEXTRINS; HEMODYNAMICS; HUMANS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84943582234     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13178     Document Type: Article

References (21)

1. Gibbs NM, Sadleir PH, Clarke RC, Platt PR,. Survival from perioperative anaphylaxis in Western Australia 2000-2009. British Journal of Anaesthesia 2013; 111: 589-93.
2. Sadleir PH, Clarke RC, Bunning DL, Platt PR,. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002-2011. British Journal of Anaesthesia 2013; 110: 981-7.
3. McDonnell NJ, Pavy TJ, Green LK, Platt PR,. Sugammadex in the management of rocuronium-induced anaphylaxis. British Journal of Anaesthesia 2011; 106: 199-201.
4. Badaoui R, Popov I, Dupont H,. A case of rocuronium-induced anaphylactic shock, improved by sugammadex. Canadian Journal of Anesthesia 2012; 59: 909-10.
5. Kawano T, Tamura T, Hamaguchi M, Yatabe T, Yamashita K, Yokoyama M,. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. Journal of Clinical Anesthesia 2012; 24: 62-4.
6. Funnell AE, Griffiths J, Hodzovic I,. A further case of rocuronium-induced anaphylaxis treated with sugammadex. British Journal of Anaesthesia 2011; 107: 275-6.
7. Barthel F, Stojeba N, Lyons G, Biermann C, Diemunsch P,. Sugammadex in rocuronium anaphylaxis: dose matters. British Journal of Anaesthesia 2012; 109: 646-7.
8. Conte B, Bonada G, Ripart J,. Reversal of a rocuronium-induced grade IV anaphylaxis via early injection of a large dose of sugammadex. Canadian Journal of Anesthesia 2014; 61: 558-62.
9. Plaud B,. A new option for the treatment of anaphylaxis linked to steroidal neuromuscular blockers: how much value should we grant to case reports? Canadian Journal of Anesthesia 2014; 61: 511-8.
10. Raft J, Belhadj-Tahar N, Meistelman C,. Slow recovery after sugammadex bolus after rocuronium-induced anaphylaxis. British Journal of Anaesthesia 2014; 112: 1115-27.
11. Clarke RC, Sadleir PH, Platt PR,. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 2012; 67: 266-73.
12. Leysen J, Bridts CH, De Clerck LS, Ebo DG,. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011; 66: 526-7.
13. Platt PR, Sadleir PHM, Clarke RC,. Sugammadex, rocuronium and mast cell numbers in the rat liver. Anaesthesia 2013; 68: 208-9.
14. Tomak Y, Yilmaz A, Bostan H, et al., Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver. Anaesthesia 2012; 67: 1101-4.
15. Tomak Y, Erdivanli B, Kalkan Y, Tumkaya L,. A reply. Anaesthesia 2013; 68: 208-9.
16. Mertes PM, Laxenaire MC, Alla F,. Groupe d'Etudes des Reactions Anaphylactoides Peranesthesiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-45.
17. Sadleir PH, Russell T, Clarke RC, Maycock E, Platt PR,. Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaesthesia and Intensive Care 2014; 42: 93-6.
18. Clarke R, Sadleir P, Van Niekerk AW, Platt PR,. Quantification of volume loss and haemodynamic changes of Gelofusine-induced anaphylaxis during cardiopulmonary bypass. Anaesthesia and Intensive Care 2011; 39: 492-5.
19. Pumphrey RS,. Fatal posture in anaphylactic shock. Journal of Allergy and Clinical Immunology 2003; 112: 451-2.
20. Brown SGA,. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Current Opinion in Allergy and Clinical Immunology 2005; 5: 359-64.
21. O'Connor RE, Domeier RM,. An evaluation of the pneumatic anti-shock garment (PASG) in various clinical settings. Prehospital Emergency Care 1997; 1: 36-44.